ALNOV:EPA
Novacyt SA
0,44 €
0,00%
(0,00) 1 d
19 nov., 11:34:51 GMT+1 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ALNOV …
Öppen
0,44 €
Högt
0,44 €
Lågt
0,44 €
Börsvärde
32,30 mn
Genomsn. vol.
136,90 tn
Volym
26,37 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Öppen
0,44 €
Högt
0,44 €
Lågt
0,44 €
Börsvärde
32,30 mn
Genomsn. vol.
136,90 tn
Volym
26,37 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Nyheter och artiklar
Från webbkällor och nyhetspartner
Business Insider
·
för 37 minuter sedan
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
The Motley Fool
·
för 55 minuter sedan
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Barron's
·
för 11 timmar sedan
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Hedgeye
·
för 20 timmar sedan
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Om Novacyt SA
VdDavid Allmond
Anställda228
Grundades3 juli 2006
Huvudkontor-
SektorHealth Care
Bransch-
Webbplatsnovacyt.com